| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |